Lipid Profile vs Lipid Panel: What Each Test Shows

Categories
Articles
Cholesterol Testing Lab Interpretation 2026 Update Patient-Friendly

A lipid profile and a lipid panel usually mean the same cholesterol blood test, but lab wording can hide useful details. The real question is not the name — it is which numbers changed and why.

📖 ~11 minutes 📅
📝 Published: 🩺 Medically Reviewed: ✅ Evidence-Based
⚡ Quick Summary v1.0 —
  1. Lipid profile usually means the same test as a lipid panel: total cholesterol, LDL-C, HDL-C, and triglycerides.
  2. Total cholesterol normal range is usually below 200 mg/dL, but LDL-C, non-HDL-C, ApoB, and overall risk matter more.
  3. Triglycerides are normal below 150 mg/dL when fasting; levels of 500 mg/dL or higher need prompt follow-up because pancreatitis risk rises.
  4. LDL cholesterol below 100 mg/dL is often considered optimal for lower-risk adults, while very high-risk patients may need targets below 70 mg/dL or even 55 mg/dL.
  5. Non-fasting lipid profile results are acceptable for many screening visits, but fasting is still useful when triglycerides are high or LDL is calculated.
  6. Calculated LDL-C can become unreliable when triglycerides are above 400 mg/dL, and a direct LDL test or ApoB may be more useful.
  7. HDL cholesterol below 40 mg/dL in men or below 50 mg/dL in women is low, but raising HDL alone has not reliably reduced heart attacks.
  8. Kantesti AI reads lipid results in context by checking units, reference ranges, trends, medications, diabetes markers, kidney function, and family risk.

Are lipid profile and lipid panel the same test?

A lipid profile and a lipid panel are usually the same cholesterol blood test. Both commonly report total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides; some labs also add non-HDL cholesterol, VLDL, cholesterol ratios, or direct LDL. On May 14, 2026, I still tell patients that the name matters less than the exact markers printed on the report. You can upload either name to Kantesti AI and compare it with our deeper lipid panel results guide.

Lipid profile report and cholesterol markers shown as a clinical lab interpretation scene
Figure 1: Different lab names often describe the same cholesterol testing set.

The confusion usually starts when one lab says lipid profile, another says lipid panel, and a third says cholesterol panel. In day-to-day clinical practice, these labels usually map to the same four core results, but I have seen international reports where a “profile” includes ApoB or Lp(a), while a “panel” does not.

Here is what matters: a lipid profile is not a diagnosis. It is a risk snapshot, and it becomes more meaningful when read beside age, blood pressure, smoking status, diabetes markers, kidney function, thyroid status, family history, and whether the sample was fasting.

A practical trick from Thomas Klein, MD: ignore the panel title for 10 seconds and circle the actual analytes. If your numbers are in mmol/L instead of mg/dL, do not compare them by eye; use a unit-aware interpretation or our guide to different lab units before worrying.

What does a standard lipid profile include?

A standard lipid profile includes total cholesterol, LDL-C, HDL-C, and triglycerides in most adult screening reports. Many modern labs also calculate non-HDL cholesterol by subtracting HDL-C from total cholesterol, which often gives a better estimate of all plaque-forming cholesterol particles.

Lipid profile laboratory sample prepared for cholesterol and triglyceride analysis
Figure 2: Most cholesterol reports share four core lipid measurements.

Total cholesterol measures cholesterol carried across several lipoprotein particles, not just the dangerous ones. A total cholesterol of 210 mg/dL can mean very different things if HDL-C is 85 mg/dL versus 35 mg/dL.

LDL-C is usually calculated, not directly measured, unless the lab orders a direct LDL method. The classic Friedewald equation in mg/dL is LDL-C = total cholesterol minus HDL-C minus triglycerides divided by 5, and that shortcut starts to fail when triglycerides climb.

Triglycerides reflect circulating fat-rich particles and recent metabolic traffic from meals, liver production, alcohol intake, insulin resistance, and some medications. Kantesti’s biomarker guide treats triglycerides as a metabolic clue, not just a cholesterol side note.

Total cholesterol normal range: useful, but limited

The usual total cholesterol normal range is below 200 mg/dL in adults. A result of 200-239 mg/dL is often called borderline high, and 240 mg/dL or higher is typically classified as high, but total cholesterol alone can overestimate or underestimate heart risk.

Lipid profile comparison showing total cholesterol as only one part of risk
Figure 3: Total cholesterol is a starting point, not the whole story.

I often meet patients who panic over a total cholesterol of 205 mg/dL while their LDL-C is 92 mg/dL, HDL-C is 78 mg/dL, and triglycerides are 70 mg/dL. That pattern is very different from total cholesterol 205 mg/dL with HDL-C 32 mg/dL and triglycerides 280 mg/dL.

Total cholesterol below 200 mg/dL is considered desirable for many adults, but it does not prove low cardiovascular risk. People with diabetes, chronic kidney disease, strong family history, or high Lp(a) can have heart risk even when total cholesterol looks “normal.”

The reason we still look at total cholesterol is simple: it feeds risk calculators and flags patterns quickly. For a broader explanation of total, LDL, and HDL ranges, keep our cholesterol range guide open next to your report.

Some European labs report total cholesterol in mmol/L, where 200 mg/dL is about 5.2 mmol/L. I see avoidable anxiety when patients compare 5.4 mmol/L to 200 mg/dL as if they are the same unit; they are not.

Desirable <200 mg/dL Often acceptable in lower-risk adults, but LDL-C and non-HDL-C still matter
Borderline High 200-239 mg/dL Needs full lipid pattern review and risk calculation
High >=240 mg/dL Often warrants clinician review, especially if LDL-C or non-HDL-C is high
Very Concerning Pattern High total cholesterol plus LDL-C >=190 mg/dL May suggest familial hypercholesterolemia or severe primary hyperlipidemia

LDL cholesterol: calculated, direct, and risk-based targets

LDL cholesterol is usually the most treatment-shaping number in a lipid profile, especially when it is 190 mg/dL or higher. For lower-risk adults, LDL-C below 100 mg/dL is commonly called optimal, while patients with established cardiovascular disease often need much lower targets.

Lipid profile artery diagram showing LDL particles and plaque risk
Figure 4: LDL interpretation depends on both concentration and patient risk.

The 2018 AHA/ACC cholesterol guideline recommends high-intensity statin therapy for adults with LDL-C of 190 mg/dL or higher, regardless of calculated 10-year risk (Grundy et al., 2019). The ESC/EAS approach is often more target-driven, with very high-risk patients frequently aiming below 55 mg/dL.

Calculated LDL-C becomes unreliable when triglycerides exceed about 400 mg/dL. In that setting, a direct LDL test or ApoB can prevent a falsely reassuring report.

A 52-year-old runner once came to clinic proud of his HDL-C of 82 mg/dL, but his LDL-C was 196 mg/dL on two separate tests. That pattern is not “balanced out” by HDL; it deserves serious family-history review and often medication discussion.

If your report says LDL-C is high but HDL-C is normal, read the pattern rather than bargaining with one good number. Our LDL normal range guide explains why LDL targets change when risk changes.

Often Optimal <100 mg/dL Reasonable for many lower-risk adults
Borderline to Mildly High 100-159 mg/dL Risk context decides urgency
High 160-189 mg/dL A risk-enhancing level, especially with family history
Severe Hypercholesterolemia >=190 mg/dL Often needs prompt clinician review and familial risk assessment

HDL cholesterol: why “good cholesterol” is not simple

HDL cholesterol below 40 mg/dL in men or below 50 mg/dL in women is considered low, but HDL-C is not a medication target in the same way LDL-C is. Very high HDL-C does not automatically cancel high LDL-C or high ApoB.

Lipid profile visualization comparing HDL particles with other cholesterol carriers
Figure 5: HDL helps risk interpretation but rarely drives treatment alone.

Most patients hear “good cholesterol” and assume more is always better. The evidence is messier: HDL-C is associated with lower risk in many populations, but drugs that simply raise HDL-C have not reliably reduced cardiovascular events.

Low HDL-C commonly travels with high triglycerides, insulin resistance, abdominal weight gain, smoking, and low physical activity. When I review a lipid profile showing HDL-C 34 mg/dL and triglycerides 240 mg/dL, I think about metabolic risk before I think about an isolated HDL problem.

HDL-C of 60 mg/dL or higher has traditionally been considered protective, but HDL function may matter more than HDL quantity. That nuance is why our low HDL guide focuses on triglycerides, glucose, waist circumference, exercise, and smoking rather than HDL-raising supplements.

Triglycerides: meals, insulin resistance, and pancreatitis risk

Triglycerides are normal below 150 mg/dL on a fasting lipid profile, borderline high from 150-199 mg/dL, high from 200-499 mg/dL, and severely high at 500 mg/dL or above. Levels near or above 1,000 mg/dL can carry substantial pancreatitis risk.

Lipid profile triglyceride-rich particles shown in a medical molecular scene
Figure 6: Triglycerides respond quickly to meals, alcohol, and insulin resistance.

Triglycerides are often the most lifestyle-sensitive number on a lipid report. A late dinner, alcohol the night before, uncontrolled diabetes, hypothyroidism, steroid use, pregnancy, and rapid weight gain can all push them up within days to weeks.

A triglyceride level of 500 mg/dL or higher should not be brushed off as a routine cholesterol issue. At that point, clinicians usually ask about diabetes control, alcohol, medications, kidney disease, thyroid disease, and genetic lipid disorders.

A non-fasting triglyceride result may be 15-30 mg/dL higher than a fasting result in many people, but some patients rise much more after meals. Our triglyceride range guide pairs well with our article on high triglycerides if your result is above 200 mg/dL.

Clinicians disagree a little on how aggressively to treat triglycerides in the 150-499 mg/dL range when LDL-C is controlled. My bias is to treat the pattern: insulin resistance, fatty liver markers, weight trajectory, alcohol intake, and non-HDL cholesterol usually tell the clearer story.

Normal Fasting <150 mg/dL Usually acceptable, though lower may be better in metabolic risk
Borderline High 150-199 mg/dL Often linked to insulin resistance, diet, alcohol, or weight changes
High 200-499 mg/dL Raises non-HDL particle burden and may affect LDL calculation
Severe >=500 mg/dL Needs prompt follow-up because pancreatitis risk rises

Do you need to fast before a lipid profile?

Many adults do not need to fast before routine lipid screening, but fasting still helps when triglycerides are high, LDL-C is calculated, or a clinician is investigating severe lipid abnormalities. A 9-12 hour fast is still commonly used for repeat testing after an abnormal triglyceride result.

Lipid profile fasting preparation scene with water and morning lab materials
Figure 7: Fasting mainly affects triglycerides and calculated LDL accuracy.

The European Atherosclerosis Society and European Federation of Clinical Chemistry consensus statement said fasting is not routinely required for determining a lipid profile (Nordestgaard et al., 2016). That statement changed practice because most people spend their day in a non-fasting state anyway.

Non-fasting triglycerides above 175 mg/dL are often considered abnormal in many clinical settings. If a non-fasting sample shows triglycerides of 280 mg/dL, I usually want to know what the person ate, whether alcohol was involved, and whether a fasting repeat confirms it.

Fasting is especially useful when triglycerides are above 400 mg/dL because calculated LDL-C can become unreliable. If you are told to fast, water is fine; our guide to fasting and lab results explains which tests actually shift.

Non-HDL cholesterol and ApoB: the particle story

Non-HDL cholesterol equals total cholesterol minus HDL cholesterol, and it captures LDL, VLDL, IDL, and other atherogenic particles. ApoB counts the main structural protein on most plaque-forming particles, so it can reveal risk when LDL-C looks deceptively normal.

Lipid profile particle count concept with ApoB and non-HDL cholesterol carriers
Figure 8: Particle burden explains risk that LDL-C alone may miss.

Non-HDL-C is useful because every triglyceride-rich remnant particle still carries cholesterol into artery walls. A non-HDL-C target is often set about 30 mg/dL higher than the LDL-C target, which is why triglyceride-heavy patterns deserve attention.

The 2018 AHA/ACC guideline lists ApoB of 130 mg/dL or higher as a risk-enhancing factor, especially when triglycerides are 200 mg/dL or higher (Grundy et al., 2019). In real practice, ApoB is one of the cleanest ways to count the traffic jam rather than just measure cargo.

I like ApoB when LDL-C and triglycerides disagree: LDL-C 105 mg/dL with triglycerides 280 mg/dL may hide more particle burden than the LDL number suggests. For deeper reading, compare our non-HDL guide with our ApoB blood test explanation.

Which lipid numbers matter most for heart risk?

The lipid numbers that usually matter most for heart risk are LDL-C, non-HDL-C, ApoB, triglycerides, and Lp(a), interpreted alongside age, blood pressure, smoking, diabetes, kidney disease, and family history. No single cholesterol result should be read outside that risk frame.

Lipid profile heart-risk scene linking cholesterol particles with artery narrowing
Figure 9: Heart risk depends on lipids plus the patient’s whole risk profile.

The Cholesterol Treatment Trialists’ meta-analysis found that each 1 mmol/L, about 39 mg/dL, reduction in LDL-C lowered major vascular events by roughly 22% across randomized statin trials (Baigent et al., 2010). That is why LDL-C reduction remains central even when newer markers are added.

Lp(a) is largely inherited and may be high even when LDL-C and triglycerides look ordinary. I check it at least once in many patients with premature heart disease in the family, especially if a parent or sibling had an event before age 55 in men or 65 in women.

Risk calculators can under-call risk in people with South Asian ancestry, inflammatory disease, early menopause, chronic kidney disease, or strong family history. Our guide to heart-risk blood tests gives a broader view than a cholesterol table alone.

The practical ordering of concern is usually: very high LDL-C first, severe triglycerides first if pancreatitis risk is present, then non-HDL-C or ApoB when particles are discordant. That order prevents two common mistakes: ignoring LDL-C of 190 mg/dL, and ignoring triglycerides of 700 mg/dL.

Why did your lipid profile change since last year?

A lipid profile can change within weeks because of weight change, diet pattern, alcohol intake, thyroid status, diabetes control, illness, pregnancy, medications, or lab variability. A 5-10% swing can be real or partly biological noise, so trends matter more than one isolated report.

Lipid profile trend tracking scene with serial cholesterol result patterns
Figure 10: Trends reveal whether a cholesterol shift is real or temporary.

LDL-C often rises with saturated fat intake, weight gain, hypothyroidism, nephrotic-range kidney protein loss, some acne medicines, and certain hormonal therapies. Triglycerides often rise with alcohol, refined carbohydrates, insulin resistance, uncontrolled diabetes, steroids, beta blockers, and some antipsychotic medications.

In our analysis of large numbers of uploaded reports, I repeatedly see the same story: a patient changes to a “healthy” diet, but LDL-C jumps because the diet is heavy in butter, coconut oil, cream, and processed low-carb snacks. Healthy branding is not the same as lipid-friendly physiology.

A meaningful LDL-C change is often considered at least 10-15%, especially when the same lab method is used. If you changed labs, changed fasting status, or were ill during testing, interpret the move cautiously.

If your cholesterol suddenly climbed, our cholesterol trend guide walks through the usual suspects. A one-time spike deserves curiosity, not panic.

Special situations: children, keto diets, pregnancy, and statins

Lipid testing needs different interpretation in children, pregnancy, low-carbohydrate diets, diabetes, and statin monitoring. The same LDL-C of 145 mg/dL may mean different next steps in a 10-year-old with family history, a pregnant patient, and a 48-year-old after a major diet change.

Lipid profile clinical planning scene for family and medication-related cholesterol risk
Figure 11: Age, diet, pregnancy, and medication use change lipid interpretation.

Children are not just small adults for cholesterol interpretation. Universal lipid screening is often considered around ages 9-11 and again around 17-21, while earlier testing is used when family history or obesity-related risk is present; our kids cholesterol guide explains those cutoffs.

Pregnancy can raise total cholesterol and triglycerides substantially, often by 30-50% or more in later gestation. Most clinicians avoid making long-term cholesterol decisions from a late-pregnancy lipid profile unless triglycerides are dangerously high.

Keto and very low-carb diets are the tricky ones. Some people improve triglycerides and HDL-C beautifully, while a smaller group develops marked LDL-C rises; when that happens, I usually want ApoB, non-HDL-C, thyroid markers, and a dietary saturated fat review before anyone declares victory.

Before starting statins, clinicians commonly check baseline liver enzymes and review pregnancy status, medication interactions, muscle symptoms, diabetes risk, and family history. Our article on pre-statin blood tests covers what is usually worth asking.

How Kantesti AI interprets a lipid report

Kantesti AI interprets a lipid profile by reading the exact lab markers, units, reference ranges, fasting status, age, sex, medications, trends, and related biomarkers such as glucose, HbA1c, TSH, ALT, creatinine, and urine albumin. The goal is context, not a red-flag list.

Lipid profile uploaded to an AI blood test analyzer in a secure clinical workspace
Figure 12: AI interpretation is strongest when it reads the full report context.

Our AI does not treat LDL-C 132 mg/dL the same way in every person. It checks whether the result sits beside diabetes-range HbA1c, high blood pressure clues, kidney markers, a family risk pattern, high triglycerides, low HDL-C, or a previous LDL-C of 95 mg/dL.

A typical user uploads a PDF or photo, and our system converts units, checks ranges, and generates an interpretation in about 60 seconds. If you want the nuts and bolts, see how our blood test PDF upload workflow handles messy reports.

Kantesti’s neural network is designed for pattern recognition across 15,000+ biomarkers and 75+ languages, with medical governance described in our clinical standards. You can also use our AI blood test analyzer when your lab calls the same cholesterol test by two different names.

When should you repeat a lipid profile?

A lipid profile is commonly repeated in 4-12 weeks after starting or changing lipid-lowering medication, major diet change, or a clearly abnormal result. Stable lower-risk adults may test less often, while high-risk patients usually need more regular monitoring.

Lipid profile retesting calendar with laboratory sample and trend review materials
Figure 13: Retesting intervals depend on treatment changes and baseline risk.

After starting a statin, a repeat lipid panel around 6-8 weeks often gives a useful early read on response and adherence. A 30-49% LDL-C reduction is expected with many moderate-intensity statins, while high-intensity therapy often aims for a 50% or greater reduction.

If triglycerides are 500 mg/dL or higher, I do not wait a year. I usually want a fasting repeat, diabetes assessment, alcohol review, medication review, and sometimes urgent treatment depending on the level and symptoms.

If LDL-C is 190 mg/dL or higher, repeat testing can confirm persistence, but it should not delay risk assessment. Familial hypercholesterolemia screening questions become relevant: tendon xanthomas, premature heart disease in relatives, and very high cholesterol in childhood.

For timing nuance, our retest timeline guide and cholesterol testing age guide are useful companions. Bring previous reports if you have them; trend beats memory.

What should you do with abnormal lipid results?

Abnormal lipid results should lead to risk sorting: confirm severe values, calculate cardiovascular risk, look for reversible causes, and choose lifestyle or medication steps based on the whole pattern. Do not change medication or start high-dose supplements from one number alone.

Lipid profile lifestyle plan with heart-healthy foods and cholesterol follow-up materials
Figure 14: Lifestyle changes work best when matched to the lipid pattern.

If LDL-C is high, focus first on saturated fat sources, soluble fiber, weight trajectory, thyroid status, and family history. If triglycerides are high, the first questions are usually alcohol, sugar/refined starch intake, diabetes control, weight change, and medications.

A practical LDL-lowering diet often includes 5-10 g/day of soluble fiber and replacement of butter, cream, and processed meats with unsaturated fats. Many patients see LDL-C move within 6-12 weeks, though the size of the response varies a lot.

Exercise tends to improve triglycerides and insulin sensitivity more reliably than it dramatically lowers LDL-C. A 150-minute weekly aerobic target plus resistance training is a reasonable starting point for many adults, assuming their clinician agrees it is safe.

Before buying a stack of supplements, read our guide to cholesterol-lowering foods. If you want an immediate interpretation of your own report, try a free blood test analysis and bring the output to your clinician.

Kantesti research publications and medical review

Kantesti publishes technical and clinical validation work so readers can see how our AI-assisted interpretation is engineered and reviewed. Lipid interpretation still needs clinician judgment, but transparent methods matter when patients are making decisions from real lab reports.

Lipid profile research review desk with medical validation papers and lab materials
Figure 15: Research transparency supports safer interpretation of real lab reports.

Thomas Klein, MD reviews lipid content with the same principle I use in clinic: a cholesterol number is only useful when the patient context is visible. Our physician review process is described through Kantesti’s Medical Advisory Board, including oversight for YMYL health content.

Kantesti AI Clinical Research Group. (2026). Multilingual AI Assisted Clinical Decision Support for Early Hantavirus Triage: Design, Engineering Validation, and Real-World Deployment Across 50,000 Interpreted Blood Test Reports. Figshare. DOI. ResearchGate. Academia.edu.

Kantesti AI Clinical Research Group. (2026). Iron Studies Guide: TIBC, Iron Saturation & Binding Capacity. Zenodo. DOI. ResearchGate. Academia.edu.

These publications are not a substitute for individualized medical care. They document engineering, validation, and educational standards behind our interpretation work, while your own lipid profile still deserves review through your personal risk factors, medications, and clinician’s judgment.

Frequently Asked Questions

Is a lipid profile the same as a lipid panel?

Yes, a lipid profile and a lipid panel usually mean the same cholesterol blood test. Most reports include total cholesterol, LDL-C, HDL-C, and triglycerides, although some labs add non-HDL cholesterol, VLDL, ratios, ApoB, or Lp(a). The safest approach is to check the actual markers listed rather than relying on the test name.

What is included in a lipid profile?

A standard lipid profile includes total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. Many labs also calculate non-HDL cholesterol, which equals total cholesterol minus HDL cholesterol. If triglycerides are above about 400 mg/dL, calculated LDL-C may be unreliable and a direct LDL-C or ApoB test may be more useful.

Do I need to fast for a lipid panel?

You often do not need to fast for routine lipid screening, especially when the goal is general cardiovascular risk assessment. Fasting for 9-12 hours is still useful when triglycerides are high, when LDL-C is calculated, or when a previous non-fasting result was abnormal. Water is allowed during a fasting lipid test unless your clinician gives different instructions.

What is the total cholesterol normal range?

The usual total cholesterol normal range is below 200 mg/dL in adults. A value of 200-239 mg/dL is commonly called borderline high, and 240 mg/dL or higher is considered high. Total cholesterol should not be interpreted alone because LDL-C, HDL-C, triglycerides, non-HDL-C, ApoB, and personal risk factors can change the meaning.

Which cholesterol number matters most?

LDL-C is often the most treatment-shaping cholesterol number, especially when it is 190 mg/dL or higher. Non-HDL cholesterol and ApoB can be more informative when triglycerides are high or LDL-C looks normal despite metabolic risk. The best interpretation also includes age, blood pressure, smoking, diabetes, kidney function, family history, and Lp(a) when appropriate.

When are triglycerides dangerous?

Triglycerides are normal below 150 mg/dL when fasting, and levels of 200-499 mg/dL are considered high. A triglyceride level of 500 mg/dL or higher needs prompt clinician follow-up because pancreatitis risk rises, especially as levels approach or exceed 1,000 mg/dL. Common causes include uncontrolled diabetes, alcohol intake, high refined-carbohydrate intake, kidney disease, hypothyroidism, and some medications.

Can HDL cancel out high LDL cholesterol?

No, high HDL-C does not reliably cancel out high LDL-C. LDL-C of 190 mg/dL or higher is clinically significant even when HDL-C is 70 mg/dL or higher. HDL-C is useful for risk assessment, but lowering LDL-C, non-HDL-C, or ApoB remains the stronger evidence-based strategy for reducing atherosclerotic cardiovascular risk.

Get AI-Powered Blood Test Analysis Today

Join over 2 million users worldwide who trust Kantesti for instant, accurate lab test analysis. Upload your blood test results and receive comprehensive interpretation of 15,000+ biomarkers in seconds.

📚 Referenced Research Publications

1

Klein, T., Mitchell, S., & Weber, H. (2026). Multilingual AI Assisted Clinical Decision Support for Early Hantavirus Triage: Design, Engineering Validation, and Real-World Deployment Across 50,000 Interpreted Blood Test Reports. Kantesti AI Medical Research.

2

Klein, T., Mitchell, S., & Weber, H. (2026). Iron Studies Guide: TIBC, Iron Saturation & Binding Capacity. Kantesti AI Medical Research.

📖 External Medical References

3

Grundy SM et al. (2019). 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Circulation.

4

Baigent C et al. (2010). Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet.

5

Nordestgaard BG et al. (2016). Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications. European Heart Journal.

2M+Tests Analyzed
127+Countries
98.4%Accuracy
75+Languages

⚕️ Medical Disclaimer

E-E-A-T Trust Signals

Experience

Physician-led clinical review of lab interpretation workflows.

📋

Expertise

Laboratory medicine focus on how biomarkers behave in clinical context.

👤

Authoritativeness

Written by Dr. Thomas Klein with review by Dr. Sarah Mitchell and Prof. Dr. Hans Weber.

🛡️

Trustworthiness

Evidence-based interpretation with clear follow-up pathways to reduce alarm.

🏢 Kantesti LTD Registered in England & Wales · Company No. 17090423 London, United Kingdom · kantesti.net
blank
By Prof. Dr. Thomas Klein

Dr. Thomas Klein is a board-certified clinical hematologist serving as Chief Medical Officer at Kantesti AI. With over 15 years of experience in laboratory medicine and a deep expertise in AI-assisted diagnostics, Dr. Klein bridges the gap between cutting-edge technology and clinical practice. His research focuses on biomarker analysis, clinical decision support systems, and population-specific reference range optimization. As CMO, he leads the triple-blind validation studies that ensure Kantesti's AI achieves 98.7% accuracy across 1 million+ validated test cases from 197 countries.

Leave a Reply

Your email address will not be published. Required fields are marked *